Advance in Therapeutics Course 2026 - From Prevention to Treatment

Open Claw and Data Security - AI Assistant for Pharmacists

Potassium‑competitive Acid Blockers: A new Era in Acid Suppression Therapy

Tecfidera ( Dimethyl Fumarate ): for the Treatment of Adult-Onset Multiple Sclerosis (AOMS) and Pediatric-Onset MS (POMS)

Interdisciplinary Case Discussion: Radiological and Urological Approaches to Prostate Cancer Diagnosis and Treatment

2027-28 Annual Plan - Head Office Forum

MGT 303 - Leading Change and Projects

HKPJ Article - Use of Aprocitentan and Spironolactone in Resistant Hypertension Management (For 2025/26 CPE cycle)

Dupixent ( Dupilumab ): Disease Modification in Atopic Dermatitis

Translating CGM Data into Patient-centred Care in Primary Healthcare

CAHMR Health Services Seminar Series No. 24

Non-clinical Assessment in Drug Development

Regulatory Services Symposium 2026 : Laboratory Accreditation Standards, Medical Device Regulations & Tour to Government Chinese Medicines Testing Institute (GCMTI) for Enhanced Regulatory Practices

Ebglyss ( Lebrikizumab ) : An Interlukin (IL) 13 Antagonist for Atopic Dermatitis (AD)

社區藥房: 基層醫療中的策略性角色

Sharing Forum on Resident Pharmacist Projects

Intelligence Leads the Future - Artificial Intelligence Reshaping the Paradigm of Clinical Pharmacy Practice

IDIC Forum: Update of Antibiotic Guidance Notes In Community Setting – Part I & Part II

The Role of Citicoline in Post-stroke and Traumatic Brain Injury

Seminar on Management of Post Covid Conditions

CAHMR Health Services Seminar Series No. 23

Case Sharing on Use of Oral Anticoagulation

推動中西醫結合治療 – 乳癌交流研討會

IO TOX MDT Roundtable: Neurological Toxicity Management of Immunotherapy

HA Staff Forum - Sharing on Sentinel and Serious Untoward Events (Mar 2025)

Merative Micromedex User Group Meeting Hong Kong & Macau Chapter

Onboarding Teprotumumab: Practical Guidance for Pharmacists and Clinicians

American Heart Association Basic Life Support (CPR and AED) Program

Vastarel MR Reviews 2026

Capacity Building Workshop 2026: Hepatitis B Management – Primary Healthcare’s Perspectives